Blue Owl Capital Corporation's net asset value (NAV) increased to $14.32 per share as of September 30, reversing a multi-quarter decline. This improvement reflects better portfolio valuations, share repurchases at significant discounts, and earnings growth. Despite trading at a 25% discount to NAV, the company’s long-term portfolio losses are minimal, and ongoing buybacks could further boost NAV. Key risks include rising watch-list loans and upcoming debt refinancing in 2027.
Blue Owl Capital's book value rise is presented here alongside Pluang's Financials-sector snapshot as of Nov 06, 2026 13:01 WIB: out of 142 US financial stocks priced, only 22 advanced while 119 declined. StoneX Group (SNEX) dropped 8.38% to USD 52.07 with a typical hold time of 11 days and purely sell orders, contrasting with Mizuho Financial Group (MFG) which fell 7.45% to USD 9.07 but saw 100% buy orders and an 8-day hold. Marex Group (MRX) also declined 7.44% to USD 65.11 with a 13-day hold time. This comparison shows varied investor sentiment and trading activity within the sector on Pluang.
Vallourec has signed a new €750 million multi-currency revolving credit facility (RCF) to replace its previous credit lines, improving its financial structure to align with an investment-grade profile. The new five-year credit line, with options to e...
Norwegian oil and gas company DNO ASA announced its shares will trade ex-dividend starting November 6, 2026. Shareholders on record as of November 9 will receive a dividend of NOK 0.375 per share, payable around November 17. This dividend reflects th...
Vallourec has signed a new €750 million multicurrency revolving credit facility (RCF) to replace its previous credit lines, improving its financial structure with better terms and lower costs. The five-year facility, coordinated by BNP Paribas and Na...
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Funko reported better-than-expected Q3 2026 results with strong international revenue growth and improved profitability metrics like EPS and EBITDA. Despite this, shares fell sharply due to tough U.S. sales comparisons from prior tariff-related inven...
